A Russian-developed nasal vaccine against six respiratory viruses may prove particularly useful to older people and patients with chronic diseases, but it is unlikely that it will completely replace routine influenza vaccine, as reported by a molecular biologist, RAN academic Peter Chumakov.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A Russian-developed nasal vaccine against six respiratory viruses may prove particularly useful to older people and patients with chronic diseases, but it is unlikely that it will completely replace routine influenza vaccine, as reported by a molecular biologist, RAN academic Peter Chumakov.